| Value | ₹28.40 Cr |
|---|
BSE filing, NSE: CHOKSILA. Summary written from the filing by ALFA Finder's alert engine.
Choksi Laboratories Ltd: key numbers
- Share price
- ₹195.30
- Market cap
- ₹136.0 Cr
- Revenue (annual)
- ₹46.01 Cr
- Net profit (annual)
- ₹1.96 Cr
- P/E (TTM)
- 62.9×Sector 52.8×
- Promoter holding
- 31.48%+0.00% QoQ
- FII holding
- 10.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Choksi Laboratories Ltd
All →Choksi Laboratories Convertible Warrants
Choksi Laboratories' proposed convertible warrants issue was rejected at its EGM on October 17, 2026. The company requests BSE to close the in-principle approval application.
Choksi Laboratories Convertible Warrants
Choksi Laboratories' EGM on 17 Oct 2026 rejected the special resolution to allot convertible warrants to promoters. 99.46% of votes polled were against, blocking the capital raise.
Choksi Laboratories Convertible Warrants
Choksi Laboratories held an EGM regarding the issuance of convertible warrants on a preferential basis. The promoters and proposed allottees abstained from voting on the resolution.
Choksi Laboratories Other Announcement
Choksi Laboratories Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Choksi Laboratories Annual General Meeting
Choksi Laboratories Ltd has scheduled an EGM for October 17, 2026, to seek shareholder approval for issuing 3.50 lakh convertible warrants at ₹177 per warrant.
- Value
- ₹6.20 Cr
Choksi Laboratories Capital Structure Change
Choksi Laboratories board approved a preferential issue of 3.5 lakh warrants to promoters at Rs 177 per warrant, totaling Rs 6.195 Crore.
- Value
- ₹6.20 Cr
Other debt & borrowing announcements
All →Neogen Chemicals Debt & Borrowing: ₹500 Cr
Neogen Chemicals approved in-principle a Rs 500 Crore corporate guarantee for Neogen Morita's borrowings, subject to shareholder approval. The company reports no adverse impact.
- Value
- ₹500.0 Cr
Satin Creditcare Network Debt & Borrowing: ₹1.83 Cr
Satin Creditcare paid Rs.1.83 Crore quarterly interest on its 10.40% April 2027 NCDs on 31 October 2026. The payment fulfils an existing debt obligation.
- Value
- ₹1.83 Cr
AAA Technologies Debt & Borrowing: ₹6 Cr
AAA Technologies approved an inter-corporate loan of up to Rs.6 Crore to Transaction Solutions International at 12% interest. Repayable on demand; share-pledge security is proposed.
- Value
- ₹6.00 Cr
Spandana Sphoorty Financial Debt & Borrowing: ₹12.5 Cr
Spandana Sphoorty partially redeemed Rs 12.50 Crore of its listed secured NCDs on 31 October 2026 by face-value redemption. Rs 200 Crore remains outstanding.
- Value
- ₹12.50 Cr
Spandana Sphoorty Financial Debt & Borrowing: ₹2.71 Cr
Spandana Sphoorty paid monthly interest of Rs 2.71 Crore across two listed secured NCD series on 30 October 2026, on time. Series-wise amounts were Rs 2.01 Crore and Rs 0.70 Crore.
- Value
- ₹2.71 Cr
Industrial Investment Trust Debt & Borrowing: ₹200 Cr
Industrial Investment Trust's board approved borrowing up to Rs. 200 Crore from banks, NBFCs and other lenders, within the Rs. 1,000 Crore shareholder limit. The enabling approval names no specific lender yet.
- Value
- ₹200.0 Cr